chr10-76885083-G-A

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_001161352.2(KCNMA1):​c.*2183C>T variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.00362 in 1,540,192 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 1 hom., cov: 30)
Exomes 𝑓: 0.0037 ( 34 hom. )

Consequence

KCNMA1
NM_001161352.2 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 4.85

Publications

0 publications found
Variant links:
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
KCNMA1 Gene-Disease associations (from GenCC):
  • generalized epilepsy-paroxysmal dyskinesia syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • Liang-Wang syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • cerebellar atrophy, developmental delay, and seizures
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 10-76885083-G-A is Benign according to our data. Variant chr10-76885083-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 300924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00245 (372/151654) while in subpopulation SAS AF = 0.02 (96/4806). AF 95% confidence interval is 0.0167. There are 1 homozygotes in GnomAd4. There are 184 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 34 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNMA1NM_001161352.2 linkc.*2183C>T 3_prime_UTR_variant Exon 28 of 28 ENST00000286628.14 NP_001154824.1 Q12791-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNMA1ENST00000286628.14 linkc.*2183C>T 3_prime_UTR_variant Exon 28 of 28 1 NM_001161352.2 ENSP00000286628.8 Q12791-1

Frequencies

GnomAD3 genomes
AF:
0.00246
AC:
373
AN:
151550
Hom.:
1
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000509
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.000855
Gnomad ASJ
AF:
0.00635
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0200
Gnomad FIN
AF:
0.000868
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.00294
Gnomad OTH
AF:
0.00288
GnomAD4 exome
AF:
0.00374
AC:
5196
AN:
1388538
Hom.:
34
Cov.:
29
AF XY:
0.00415
AC XY:
2843
AN XY:
684596
show subpopulations
African (AFR)
AF:
0.000608
AC:
19
AN:
31242
American (AMR)
AF:
0.00120
AC:
41
AN:
34288
Ashkenazi Jewish (ASJ)
AF:
0.00413
AC:
103
AN:
24916
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35376
South Asian (SAS)
AF:
0.0173
AC:
1337
AN:
77076
European-Finnish (FIN)
AF:
0.00105
AC:
50
AN:
47798
Middle Eastern (MID)
AF:
0.0101
AC:
57
AN:
5666
European-Non Finnish (NFE)
AF:
0.00315
AC:
3385
AN:
1074528
Other (OTH)
AF:
0.00354
AC:
204
AN:
57648
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
213
426
638
851
1064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00245
AC:
372
AN:
151654
Hom.:
1
Cov.:
30
AF XY:
0.00248
AC XY:
184
AN XY:
74070
show subpopulations
African (AFR)
AF:
0.000507
AC:
21
AN:
41408
American (AMR)
AF:
0.000854
AC:
13
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00635
AC:
22
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.0200
AC:
96
AN:
4806
European-Finnish (FIN)
AF:
0.000868
AC:
9
AN:
10366
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.00294
AC:
200
AN:
67930
Other (OTH)
AF:
0.00286
AC:
6
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00254
Hom.:
0
Bravo
AF:
0.00207
Asia WGS
AF:
0.00751
AC:
26
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Generalized epilepsy-paroxysmal dyskinesia syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.23
CADD
Benign
18
DANN
Benign
0.88
PhyloP100
4.9
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201067003; hg19: chr10-78644841; API